Industry - Academia Collaboration

Search documents
Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research
Globenewswireยท 2025-09-03 07:45
Core Insights - Fangzhou Inc. is collaborating on a National Natural Science Foundation of China (NSFC) project focused on human-AI collaboration in healthcare, marking its second NSFC-backed research partnership [1][2][3] Group 1: Project Details - The study will investigate how human-AI collaboration models influence consumer adoption of healthcare products and services, specifically in the area of "AI + chronic disease management" [2] - Fangzhou is the sole corporate partner in this project, contributing to real-world data collection and model optimization [2] - The project aims to enhance academic understanding in AI and cognitive science while promoting the application of AI in healthcare [2][4] Group 2: Previous Contributions - Fangzhou previously participated in an NSFC project in 2024 that focused on AI supervision and online consumer behavior [3] - These projects highlight Fangzhou's commitment to advancing industry-academia collaboration and enhancing AI innovation in healthcare [3] Group 3: Strategic Importance - The company's involvement in NSFC projects aligns with China's strategic priority on artificial intelligence, as outlined in recent State Council guidelines [4] - The NSFC approvals are intended to address consumer adoption of AI-enabled products and services, supporting the broader "AI+" initiative [4] Group 4: Investment in Innovation - Fangzhou has made significant investments in research talent and AI innovation, with its "H2H Smart Healthcare Ecosystem" recognized as an outstanding "AI+" solution in 2024 [5] - The company has developed a talent development system that combines academic knowledge with industry expertise [5] Group 5: Future Goals - Fangzhou plans to strengthen its participation in national research initiatives and build integrated industry-academia-research innovation platforms [6] - The goal is to translate academic achievements into public healthcare services, contributing to the "Healthy China 2030" objectives [6] Group 6: Company Overview - Fangzhou Inc. serves 52.8 million registered users and 229,000 physicians as of June 30, 2025, specializing in online chronic disease management and precision medicine solutions [8]